Connect with us

National

Mission accomplished or another setback?

‘Don’t Ask, Don’t Tell’ compromise draws mixed reactions

Published

on

President Barack Obama's administration endorsed Monday a path to repeal the law that prohibits gays, lesbians and bisexuals from serving openly in the U.S. armed forces. (Photo by Pete Souza, courtesy of White House))

The legislative compromise that “Don’t Ask, Don’t Tell” repeal supporters in Congress unveiled this week has inspired mixed reactions and led LGBT leaders to advocate for its passage even as some expressed disappointment over its shortcomings.

Among those expressing displeasure was Lt. Dan Choi, a gay U.S. Army infantry soldier who was arrested twice for chaining himself to the White House fence in protest of “Don’t Ask, Don’t Tell.”

In an interview with the Blade on Monday, Choi said the proposal requires LGBT people to compromise themselves without getting much in return.

“In a compromise, it’s insinuated that both sides have given something, and I don’t see that,” he said. “So it’s too generous to call it that. It’s a delay and it’s asking us to further put our political agenda before the needs of the soldiers, and that’s who’s getting compromised.”

Despite his disappointment in the compromise language, Choi said he didn’t want the measure to fail this week when it came before Congress. He noted that “it’s only one step” in the path for non-discrimination in the U.S. military and people should keep fighting.

The measure in the Senate was made public Monday by Sen. Joseph Lieberman (I-Conn.), the sponsor of standalone legislation for repeal in the Senate. On Tuesday, Rep. Patrick Murphy (D-Pa.), champion of standalone repeal legislation in the House, unveiled an identically worded companion bill.

The Senate Armed Services Committee and the full House were expected to vote on the “Don’t Ask, Don’t Tell” measures this week during consideration of Pentagon budget legislation known as the fiscal year 2011 defense authorization bill. Neither vote occurred before Blade deadline.

The measures presented by Lieberman and Murphy would repeal the “Don’t Ask, Don’t Tell” statute mandating that openly gay, lesbian and bisexual people be discharged from the U.S. armed forces.

However, the law would only be repealed after the Pentagon completes its study — due Dec. 1 — on how to implement repeal in the U.S. military.

Further, President Barack Obama, Defense Secretary Robert Gates and Chairman of the Joint Chiefs of Staff Adm. Michael Mullen would have to certify that the U.S. military is ready for the transition and that the change “is consistent with the standards of military readiness, military effectiveness, unit cohesion and recruiting and retention.”

The legislation doesn’t give a timeline when the president, the defense secretary and the chairman of the Joint Chiefs of Staff would have to issue the certification. On Monday, the Associated Press reported that meeting those conditions for repeal would allow the Pentagon “perhaps even years” to prepare for repeal.

Notably, the legislation also lacks non-discrimination language and would return authority on discharging LGBT service members to the Pentagon.

Choi said the provisions in the legislation are “essentially compromising the integrity of the soldiers until a time to be determined” and compared the lack of a deadline for certification to a military commander issuing an order without a timeline.

“It’s devastating to the soldiers who don’t know and it leaves a lot of questions out there,” Choi said. “My question back to the president is how long are we going to force our soldiers to lie? Nobody can answer the question when.”

But Choi said “what bothers” him the most is the absence of the non-discrimination language that was contained in the standalone version of the bill.

“I thought the most heinous part of ‘Don’t Ask, Don’t Tell’ was that it enforced discrimination, and now it just says that’s altogether not as important,” Choi said. “I think it’s within everybody’s mandate to get rid of discrimination where it exists.”

Choi said as a result of the compromise, LGBT soldiers could be subject to a policy that’s “turbulent and precarious.”

Also expressing disappointment about the lack of non-discrimination language was Alex Nicholson, executive director of Servicemembers United, who said removal of the non-discrimination language was “unnecessary” to get more support for repeal.

“I think we would have been in the same position had we not made three concessions and only made two,” he said. “Other minority groups have not received statutory non-discrimination protection in the military — this would have been something extra — but it was something we were on track to secure.”

Aubrey Sarvis, executive director of the Servicemembers Legal Defense Network, said he’s not sure who initiated the idea of omitting non-discrimination language, but said those supporting repeal thought such a move would improve its chances of passage.

“It’s not anything that SLDN volunteered to give up,” Sarvis said. “I think at the end of the day, we all realized that we would have to live with this new compromise.”

The idea of removing non-discrimination language and returning authority on discharges to the Pentagon was advanced previously by the Palm Center, a think tank on gays in the military. Earlier this month, the Blade reported that the Palm Center had been asking other LGBT groups to support such a move.

But Aaron Belkin, director of the Palm Center, said he didn’t know why the non-discrimination language was removed and noted that Palm wasn’t active in pushing for such a move as part of the compromise measure.

“This was news to me when I was told,” he said. “I was actually in bed when I was told and I promise you we had nothing to do with it.”

Still, Belkin said passing legislation with non-discrimination language is “not politically realistic” and the compromise measure advanced earlier this week is “what we can get.”

But Nicholson said the Palm Center pushed hard to have the non-discrimination language removed from the legislation, noting recent reports in which Belkin advocated the proposal.

Nicholson said Belkin was responsible for Saturday’s opinion piece in the Washington Post in which former Chairman of the Joint Chiefs of Staff Gen. John Shalikashvili advocated for a return of authority to the Pentagon.

“There’s been no secret about that fact that the Palm Center has lobbied hard to take out the non-discrimination language, including the [Shalikashvili] op-ed and several other pieces of media that the Palm Center has done,” Nicholson said.

Compromise brought White House support

While the compromise fell short of what repeal supporters initially sought, the conditions set forth in the proposal brought support from the White House, which opponents of “Don’t Ask, Don’t Tell” had long sought.

In a letter published Monday, Peter Orzag, director of the Office of Management & Budget, writes the repeal measure adheres to the Pentagon’s request to finish its study on the issue at the end of the year and therefore is supported by the Obama administration.

Orzag says that the Pentagon review would be “ideally” completed before Congress takes action on the issue, but notes the administration “understands that Congress has chosen to move forward with the legislation now and seeks the administration’s views on the proposed amendment.”

In the letter, Orzag says he understands the amendment would ensure implementation of repeal is consistent with “standards of military readiness, effectiveness, unit cohesion, recruiting and retention.”

“The administration therefore supports the proposed amendment,” Orzag writes.

Geoff Morrell, a Pentagon spokesperson, issued a statement Tuesday saying Gates supports the measure, although he still believes Congress should hold off on tackling the issue until after the Pentagon completes its study.

“Secretary Gates continues to believe that ideally the [Defense Department] review should be completed before there is any legislation to repeal the ‘Don’t Ask, Don’t Tell’ law,” he said. “With Congress having indicated that is not possible, the secretary can accept the language in the proposed amendment.”

Having earned support from the administration, Sarvis said the amendment is “a path to repeal” and predicted that its passage could lead to open service “by the end of the first quarter of next year.”

After the review is complete and certification happens, Sarvis said the Pentagon “would then be free” to implement regulations for open service and Obama could issue an executive order for non-discrimination in the U.S. military.

“In fact, all of the federal policies of non-discrimination have been issued by executive order since 1948,” Sarvis said, referring to the order that President Truman issued to end racial segregation in the armed forces.

Sarvis said he didn’t think a future administration would tamper with such an executive order or “try to tinker with this and make it a political football.”

“For instance, the four executive orders that I’ve referred to since 1948 have not been undone by new administrations,” Sarvis said. “I think that if the president issues an executive order after ‘Don’t Ask, Don’t Tell’ is eliminated — I don’t see a new Congress or a new administration trying to undo an executive order.”

But Choi said he doesn’t want supporters of “Don’t Ask, Don’t Tell” repeal mistaking the Orzag letter in support of the proposal as Obama taking action on the issue. He noted the president could have transmitted repeal language to Congress for the defense budget legislation.

“Obviously, if he would have put the defense authorization bill language through to include the repeal legislation, then we wouldn’t be in this situation where he’s trying to get us to celebrate a win,” Choi said.

To follow-up on his earlier arrests at the White House and put more pressure on the president, Choi said he plans to take part in new acts of civil disobedience to draw attention to the issue of LGBT service members serving openly in the U.S. military.

“I not only plan to, but I encourage everybody else to,” Choi said. “The fact of the matter is so long as telling the truth is considered civil disobedience, we need to be committing civil disobedience every single day.”

Mission accomplished?

Several major LGBT organizations issued statements this week praising the “Don’t Ask, Don’t Tell” compromise shortly after it was announced.

In a statement, Human Rights Campaign President Joe Solmonese said Monday the new support from the administration means people rallying against “Don’t Ask, Don’t Tell” are “on the brink of historic action to both strengthen our military and respect the service of lesbian and gay troops.”

“Today’s announcement paves the path to fulfill the president’s call to end ‘Don’t Ask, Don’t Tell’ this year and puts us one step closer to removing this stain from the laws of our nation,” Solmonese said.

Nicholson of Servicemembers United said in a statement that Monday’s letter was “long awaited, much needed, and immensely helpful.”

Choi said the organizations apparently had their statements “all set up” to celebrate the compromise regardless of the deal’s content.

“Just from my military perspective, it seems very much like they’re putting a ‘mission accomplished’ banner on top of a carrier, and saying our part is done and we have fulfilled our mission,” Choi said. “For people to revel in this kind of celebration instead of encouraging people to demand the fullness of repeal of ‘Don’t Ask, Don’t Tell’ is certainly a misstep.”

Other LGBT groups that advocate for “Don’t Ask, Don’t Tell” repeal as one issue in their portfolios indicated support for the compromise measure, although they acknowledged some shortcomings.

In a statement to the Blade, Rea Carey, executive director of the National Gay & Lesbian Task Force, said her organization was “encouraged” that Congress and the administration was “taking a step” to address the legal discrimination of “Don’t Ask, Don’t Tell.”

“This presents a path that could end in men and women being able to serve openly, honestly and to great benefit of our country, but it falls short of providing clear assurances of protection and a specific timeline for implementation,” she said. “The important action this week is to ensure passage of this step toward full repeal.”

In another statement, Kate Kendell, executive director of the National Center for Lesbian Rights, offered a similarly lukewarm statement on the compromise measure.

“The amendment and compromise fall short of an outright repeal, which was what we had all been hoping for,” she said. “While we are cautiously optimistic that this agreement will lead to a full repeal, it is not yet time to celebrate the end of this appalling and shameful law.”

Among the organizations to strongly support the White House’s endorsement of the compromise was SLDN. In a statement, Sarvis called the agreement a “dramatic breakthrough.”

In response to Choi’s criticism of the statements of support for reaching an agreement with the White House, Sarvis said he respects Choi’s service and commitment to overturning “Don’t Ask, Don’t Tell.”

“His view of the legislative process and the strategy is not a view that I share,” Sarvis said. “On this one, in terms of legislative strategy and timing, I have a different view and my view is I want to get what’s realistic and I want to get something that will ensure that service members can serve openly as soon as possible.”

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular